Adjunctive taurine shows mixed results in first ‐episode psychosis

Twelve weeks of adjunctive treatment with the inhibitory neuromodulatory amino acid taurine improved psychiatric symptomatology but not cognition relative to placebo in young adult patients being treated for first‐episode psychosis, a new study has found. Researchers suggested that these results warrant further investigation of taurine in larger randomized trials.

Source: The Brown University Psychopharmacology Update - February 20, 2017 Category: Psychiatry Tags: What's New in Research Source Type: research